Alforex News

Alflorex® Wins Best Gastrointestinal Product Award

Alflorex® has won the best Gastrointestinal product for the second year running in the highly regarded Irish Pharmacy News (IPN) Awards 2017.  These awards acknowledge the innovation, dedication, and achievements from some of the leading companies in the pharmacy sector.

Alflorex® has previously attained the ‘Best Irish Pharmacy Product’ in 2015, the ‘Best Natural Product’ and the ‘Best GI (Gastrointestinal) Product’ in 2016. A successful third year of accolades was achieved by the brand against strong competition. The product was named the ‘Best GI (Gastrointestinal) Product’, for the second year running for 2017.  If you would like more information on Alflorex® please visit the website

About Alimentary Health.

Alimentary Health (AH) is an innovative Irish healthcare company and a global pioneer in discovery, development and commercialisation of proprietary bacterial and pharmabiotic treatments. Our new and breakthrough scientific research is recognised around the world as being at the cutting edge of discovery and application. AH is the foundation industry partner of the APC Microbiome Institute based at University College Cork, Ireland.

AH’s mission is to develop clinically supported microbiome based healthcare and nutritional products that health professionals can believe in. The company focuses on isolation, characterization, clinical evaluation and formulation of unique bacterial strains and their actives for inflammatory and infectious conditions, reflecting our expertise in gastrointestinal medicine, the brain-gut axis, metabolic health and nutrition.  If you would like to learn more about Alimentary Health, please visit the website

Recent Articles

Cancer Killers

Fusion Pharmaceuticals Announces Investment from Canada Pension Plan Investment Board

Hamilton, ON & Boston, MA – January 13, 2020 – Seroba’s portfolio company, Fusion Pharmaceuticals Inc., a clinical-stage precision oncology […]

Read More
Quanta News

Quanta Announces Collaboration with B. Braun Avitum UK Ltd

Alcester, Warwickshire, UK, 13 January 2020: Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical technology […]

Read More
Pq Bypass News 2

CMS Approves Coverage for PQ Bypass TORUS 2 IDE Trial

Seroba’s portfolio company, PQ Bypass Inc, a medical device company bringing new advancements to the treatment of peripheral artery disease […]

Read More
Cordella PA Sensor Coin

Endotronix Announces Positive Data from the SIRONA First-in-Human Trial for the Cordella™ PA Pressure Sensor System

LISLE, IL – November 18, 2019 – Seroba’s portfolio company, Endotronix, a digital health and medical technology company dedicated to […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top